Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Annelise Capossela/Axios
The Food and Drug Administration on Tuesday authorized the first over-the-counter, at-home rapid coronavirus test, which allows users to get their results from an app.
The big picture: A slew of at-home tests are in development, which could make diagnostics easier and faster as the pandemic rages on.
The state of play: Several companies are working on at-home test kits that deliver results digitally, the Wall Street Journal notes.
- Ellume, the company that received FDA authorization for its at-home test on Tuesday, is working on a function that would let users share their results with their doctor and local health authorities.
- The FDA asked Lucira Health, which is working on a rapid test, to develop a mobile app or website for better data tracking.
- Gauss Surgical and Cellex's test would require users take a photo of their results for an algorithm's interpretation.
- On Wednesday, the BinaxNOW COVID-19 Ag Card Home Test was authorized for use by patients at home with a prescription, and will be paired with telehealth options.